Celia Andreu-Agullo
Director, Biomarkers at Volastra Therapeutics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Volastra Therapeutics
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Director, Biomarkers
-
Jun 2022 - Present
-
-
-
-
Principal Scientist (Translational Medicine)
-
Jan 2020 - Jun 2022
- Provide scientific and strategic support to advance our miRNA-target discovery platform, the foundation of Inspirna's therapies. - Analysis of biomarker data from DNA, RNA and immune cells of clinical samples from Phase 1b/2 clinical trials. - Biomarker discovery and validation. Method development as companion diagnostic (CDx) used in our clinical trials. - Work closely with Clinical Operations team and clinical trial CROs.
-
-
Senior Scientist
-
Apr 2016 - Jan 2020
- Responsible for preclinical study design, monitoring, data generation, analysis and interpretation relevant to translational research. - Plan, design and execute pre-clinical IND-enabling pharmacology, toxicology and tumorigenic studies. - Provide scientific and operational management of the translational biology function. - Identify CROs to conduct preclinical studies in the oncology field.
-
-
-
MSKCC
-
United States
-
Hospitals and Health Care
-
Research Associate
-
Feb 2014 - Apr 2016
-
-
Research Fellow
-
Apr 2009 - Jan 2014
-
-
-
University of Valencia
-
Higher Education
-
PHD Student
-
Jan 2002 - Jun 2008
-
-